The Strategist

Abbott resumes production of Similac infant formula at Michigan plant

08/29/2022 - 10:07

According to Reuters, Abbott Laboratories has restarted making Similac infant formula at a facility in Sturgis, Michigan.

Mike Mozart via flickr
Mike Mozart via flickr
Following allegations of bacterial infections in children who consumed locally produced products, Abbott, the leading supplier of infant formula in the U.S., recalled Similac and other infant formula products made at the Michigan factory in February.

In order to address the shortage, American health authorities loosened import regulations and brought in millions of cans of food from firms like Nestle SA and Reckitt Benckiser.

Early last month, Abbott briefly reopened the Michigan factory; however, it was forced to shut down once more two weeks later due to damage from the flooding and strong rains. Now that Similac is in production, the business stated that it would take roughly six weeks for the product to start shipping to retail locations.

The resumption of Similac production in Michigan is a significant step, but Abbott CEO Robert Ford vowed that the company would not stop until this product was once again available on store shelves. "We know the national shortage of infant formula has been a hardship for the families we serve," Ford said.